SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India spurts on eyeing to launch 100 products over next five years

27 Aug 2018 Evaluate

Abbott India is currently trading at Rs. 7750.00, up by 149.50 points or 1.97% from its previous closing of Rs. 7600.50 on the BSE.

The scrip opened at Rs. 7630.00 and has touched a high and low of Rs. 7778.95 and Rs. 7630.00 respectively. So far 310 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 8199.00 on 06-Aug-2018 and a 52 week low of Rs. 4035.00 on 18-Sep-2017.

Last one week high and low of the scrip stood at Rs. 8010.00 and Rs. 7514.15 respectively. The current market cap of the company is Rs. 16457.58 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.30% and 15.72% respectively.

Abbott India is eyeing to launch around 100 products over the next five years with an aim to strengthen existing therapy areas such as gastroenterology, metabolics, vaccines, central nervous system and women's health. The company is also looking at strengthening its over-the-counter portfolio with a wider range of product formats. The company had launched 21 new products in the country during last fiscal year.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×